Sign in

CIK 0001062822

  • Non-accelerated filer
  • Smaller reporting company

LEXICON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
LXRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760474169
Phone
+1 281-863-3000
Business address
2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
Former names
LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
  1. 4 Open-market buy VP, Human Resources bought 6,000 shares at $1.84 ($11,040)
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $2.16 ($21,600)
  5. 4 Open-market buy VP, Human Resources bought 10,000 shares at $2.43 ($24,300)
  6. 4 Open-market buy Chief Executive Officer bought 20,000 shares at an average $2.34 ($46,742)
  7. 4 Open-market buy Chief Executive Officer bought 40,000 shares at $2.31 ($92,400)
  8. 4 Open-market buy President and CFO bought 12,000 shares at an average $2.33 ($28,000)
  9. 4 Open-market buy Director bought 27,775,050 shares at $2.60 ($72,215,130)
  10. 4 Exercise or conversion Director acquired 9,302 shares (option exercise)
  11. 4 Exercise or conversion Director acquired 9,302 shares (option exercise)
  12. 4 Exercise or conversion Director acquired 9,302 shares (option exercise)
  13. 4 Exercise or conversion Director acquired 9,302 shares (option exercise)
  14. 4 Exercise or conversion Director acquired 9,302 shares (option exercise)
  15. 4 Exercise or conversion Director acquired 9,302 shares (option exercise)
  16. 4 Exercise or conversion Director acquired 9,302 shares (option exercise)
  17. 4 Exercise or conversion Director acquired 9,302 shares (option exercise)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 34 · 673 filings